Our findings in BBN-induced urothelial carcinomas and bladder tumor organoids strongly suggested that the loss of Shh expression in invasive urothelial carcinomas results from the hypermethylation of the CpG shore in the Shh promoter region. Here, SHH is linked to urothelial carcinoma.